Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Inflammation 100%
• Diseases 100%
• Coronavirinae 50%
• Syndrome 50%
• Deterioration 50%
• Severe Acute Respiratory Syndrome 50%
• Hemophagocytic Syndrome 50%
• Cytokine Release Syndrome 50%
• Immune Reconstitution Inflammatory Syndrome 50%

Medicine and Dentistry

• Serositis 100%
• COVID-19 100%
• Cell Therapy 100%
• Clinical Trial 40%
• Deterioration 20%
• Immune Disorder 20%
• Severe Acute Respiratory Syndrome 20%
• Inflammatory Disorder 20%
• Diseases 20%
• Hemophagocytic Syndrome 20%
• Supportive Care 20%
• Immune Reconstitution Inflammatory Syndrome 20%
• Cytokine Release Syndrome 20%